Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 88Terminated 42Recruiting 40Active not recruiting 20Unknown 7Withdrawn 5No longer available 2Suspended 1Not yet recruiting 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 71Genitourinary 11Thoracic 10Gastrointestinal 9Head & Neck 7Breast 6Sarcoma 5Gynecologic 5Endocrine 2Lymphoid 1Classical hematology 1CNS 1

Conditions

Glioblastoma 82Brain Neoplasms 79Glioma 63Neoplasms 16Neuroblastoma 15Meningioma 14Medulloblastoma 13Neurofibromatosis 1 10Ependymoma 10Meningeal Carcinomatosis 9Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 8Neurologic Manifestations 6Diffuse Intrinsic Pontine Glioma 6Astrocytoma 6Spinal Cord Neoplasms 5Recurrence 5Central Nervous System Neoplasms 5Pheochromocytoma 4Paraganglioma 4Oligodendroglioma 4Lung Neoplasms 4Sarcoma 3Rhabdoid Tumor 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neuroma, Acoustic 3Neurofibroma, Plexiform 3Head and Neck Neoplasms 3Ganglioneuroblastoma 3

Interventions

Temozolomide 1Pemetrexed 1Paclitaxel 1Nivolumab 1Gemcitabine 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Melanoma × CNS × Clear all
NCT07492680 2026-05-29

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Bristol-Myers Squibb

Phase 2 Not yet recruiting
260 enrolled
CNSDermatologicGastrointestinal

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡